Trial NCT02795884

View at ClinicalTrials.gov 
Org. Study IDs: 4-2015-0926

Last trial update was posted on 2016-12-30

MeSH Interventions

Cisplatin Erlotinib Hydrochloride Pemetrexed Vinorelbine

MeSH Conditions


Other Conditions

NSCLC

Stopping Reasons

Because of reconsideration of using erlotinib(EGFR Tyrosine kinase inhibitor) as adjuvant aim

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID